Stay updated with breaking news from Sun Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On August 22, 2023, the Federal Circuit issued a nonprecedential decision holding that claims directed to deuterated analogs of ruxolitinib were unpatentable as obvious. Sun Pharm....
On August 22, 2023, the Federal Circuit issued a nonprecedential decision holding that claims directed to deuterated analogs of ruxolitinib were unpatentable as obvious. Sun Pharm. Indus
On August 22, 2023, the Federal Circuit affirmed an IPR Final Written Decision holding claims to deuterated derivatives of ruxolitinib unpatentable as obvious and rejected the...
Flecainide Market | Amneal Pharm, Ani Pharms, Aurobindo Pharma
Markets halted 4-consecutive days winning streak on Wednesday ahead of GDP data, with banking stocks being the top laggards while smallcap stocks outperformed. Despite maintaining outperformance compared to global cues, Sensex fell 0.55% to 62,622.24, while Nifty 50 shed 0.53% to 18,534.40.